BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2930553)

  • 1. Adverse effects of anti-tumor drug, cisplatin, on rat kidney mitochondria: disturbances in glutathione peroxidase activity.
    Sugiyama S; Hayakawa M; Kato T; Hanaki Y; Shimizu K; Ozawa T
    Biochem Biophys Res Commun; 1989 Mar; 159(3):1121-7. PubMed ID: 2930553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats.
    Atessahin A; Yilmaz S; Karahan I; Ceribasi AO; Karaoglu A
    Toxicology; 2005 Sep; 212(2-3):116-23. PubMed ID: 15946783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-phycocyanin prevents cisplatin-induced mitochondrial dysfunction and oxidative stress.
    Fernández-Rojas B; Rodríguez-Rangel DS; Granados-Castro LF; Negrette-Guzmán M; León-Contreras JC; Hernández-Pando R; Molina-Jijón E; Reyes JL; Zazueta C; Pedraza-Chaverri J
    Mol Cell Biochem; 2015 Aug; 406(1-2):183-97. PubMed ID: 25971372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective Role of Selenium and High Dose Vitamin E against Cisplatin - Induced Nephrotoxicty in Rats.
    Aksoy A; Karaoglu A; Akpolat N; Naziroglu M; Ozturk T; Karagoz ZK
    Asian Pac J Cancer Prev; 2015; 16(16):6877-82. PubMed ID: 26514460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of ellagic acid against cisplatin-induced nephrotoxicity and oxidative stress in rats.
    Ateşşahín A; Ceríbaşi AO; Yuce A; Bulmus O; Cikim G
    Basic Clin Pharmacol Toxicol; 2007 Feb; 100(2):121-6. PubMed ID: 17244261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cis-diamminedichloroplatinum(II) nephrotoxicity and its relationship to renal gamma-glutamyl transpeptidase and glutathione.
    Leyland-Jones B; Morrow C; Tate S; Urmacher C; Gordon C; Young CW
    Cancer Res; 1983 Dec; 43(12 Pt 1):6072-6. PubMed ID: 6139163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against cisplatin-induced nephrotoxicity by Spirulina in rats.
    Mohan IK; Khan M; Shobha JC; Naidu MU; Prayag A; Kuppusamy P; Kutala VK
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):802-8. PubMed ID: 16552571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection effects of Taurine supplementation against cisplatin-induced nephrotoxicity in rats.
    Saad SY; Al-Rikabi AC
    Chemotherapy; 2002 Mar; 48(1):42-8. PubMed ID: 11901256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria.
    Santos NA; Bezerra CS; Martins NM; Curti C; Bianchi ML; Santos AC
    Cancer Chemother Pharmacol; 2008 Jan; 61(1):145-55. PubMed ID: 17396264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carnosic acid attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity.
    Sahu BD; Rentam KK; Putcha UK; Kuncha M; Vegi GM; Sistla R
    Food Chem Toxicol; 2011 Dec; 49(12):3090-7. PubMed ID: 21930180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selenium attenuates docetaxel-induced apoptosis and mitochondrial oxidative stress in kidney cells.
    Baş E; Naziroğlu M
    Anticancer Drugs; 2019 Apr; 30(4):339-346. PubMed ID: 30875346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selenium and lycopene attenuate cisplatin-induced testicular toxicity associated with oxidative stress in Wistar rats.
    Salem EA; Salem NA; Maarouf AM; Serefoglu EC; Hellstrom WJ
    Urology; 2012 May; 79(5):1184.e1-6. PubMed ID: 22546410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial modulation by Epigallocatechin 3-Gallate ameliorates cisplatin induced renal injury through decreasing oxidative/nitrative stress, inflammation and NF-kB in mice.
    Pan H; Chen J; Shen K; Wang X; Wang P; Fu G; Meng H; Wang Y; Jin B
    PLoS One; 2015; 10(4):e0124775. PubMed ID: 25875356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of selenium on Cisplatin-induced nephrotoxicity in rats.
    Fujieda M; Naruse K; Hamauzu T; Miyazaki E; Hayashi Y; Enomoto R; Lee E; Ohta K; Wakiguchi H; Enzan H
    Nephron Exp Nephrol; 2006; 104(3):e112-22. PubMed ID: 16837816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversion by ozone treatment of acute nephrotoxicity induced by cisplatin in rats.
    González R; Borrego A; Zamora Z; Romay C; Hernández F; Menéndez S; Montero T; Rojas E
    Mediators Inflamm; 2004 Dec; 13(5-6):307-12. PubMed ID: 15770045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on the mechanism of protective effect of selenium on nephrotoxicity of cis-diamminedichloroplatinum (CDDP) in mice].
    Araya Y; Miyamoto H; Kondo T; Isobe H; Shimizu T; Ishiguro A; Harada M; Haneda H; Kawakami Y
    Gan To Kagaku Ryoho; 1990 Oct; 17(10):2083-9. PubMed ID: 2221931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ethanol extract of Sphaeranthus indicus on cisplatin-induced nephrotoxicity in rats.
    Mathew JE; Joseph A; Srinivasan K; Dinakaran SV; Mantri A; Movaliya V
    Nat Prod Res; 2012; 26(10):933-8. PubMed ID: 21790496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between selenium and protein synthesis in cells and subcellular fractions in rat liver.
    Jia XA; Zhou LH; Wu YN; Xia WL; Xiang RH; Yang JG; Ji ZS; Wang P; Zhang YL
    J Trace Elem Electrolytes Health Dis; 1989 Mar; 3(1):29-34. PubMed ID: 2485227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria.
    Santos NA; Catão CS; Martins NM; Curti C; Bianchi ML; Santos AC
    Arch Toxicol; 2007 Jul; 81(7):495-504. PubMed ID: 17216432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain.
    Kruidering M; Van de Water B; de Heer E; Mulder GJ; Nagelkerke JF
    J Pharmacol Exp Ther; 1997 Feb; 280(2):638-49. PubMed ID: 9023274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.